KANION PHARMACEUTICAL
R&D

R&D

Introduction of the Research Institute

Introduction of the Research Institute

文章附图

Adhering to theinnovative spirit of "Do professional work with erudite thinking, holdgreat kindness and ambition in heart”, the institute is guided by TCM theory,focus on the field of advantages of TCM and uses the frontier and advancedtechnology to develop the internationally advanced and clinically recognizedinnovative TCM, so as to promote the standardization, modernization and internationalizationof TCM.

After more than20 years of continuous development and accumulation of innovation, it has builtscientific research centers in Lianyungang, Nanjing, Shanghai and other citiesin Jiangsu, and has a complete and systematic R & D platform for the entireprocess of innovative TCM discovery - R & D - post-authorizationre-evaluation. The experimental area reaches 30,000m2, theinstruments and equipments originally value 160 million yuan, and the annual R& D investment accounts for more than 7% of sales revenue. The company hasnational scientific research platforms such as "State Key Laboratory ofNew Tech for Chinese Medicine Pharmaceutical Process", "NationalLocal Joint Engineering Center for Intelligent Manufacturing of Chinese PatentMedicines", "National Major New Drug Manufacturing EnterpriseComprehensive Large Platform", "National Postdoctoral ResearchWorkstation", "National-Recognized Enterprise TechnologyCenter", etc..

The institute hasdeveloped more than 40 new Chinese medicines and has submitted more than 600patent applications with more than 300 patents authorized; Cinnamomi RamulusPoria Capsules, one of the compound Chinese medicines, was applied inpharmaceutical form by Ministry of Science and Technology as the first projectfor the United States FDA registration and have completed phase 2 clinicaltrials in the United States; The company has been awarded 1 second prize of theState Award for Inventions, 2 second prize for National Progress in Science andTechnology, 8 first prize for Provincial Progress in Science and Technology,and more than 20 awards for Municipal Progress in Science and Technology.

A breakthrough inkey technologies of Chinese medicine pharmaceutical in-process control andintelligent manufacturing is made relying on the State Key Laboratory of NewTech for Chinese Medicine Pharmaceutical Process, and the first DigitalizedIntelligent Manufacturing Factory of Chinese Medicine was built in March 2015,which is the first pilot project approved by the Ministry of Industry andCredit in the Chinese medicine industries. It makes intelligent,informationized, digitized and dynamically optimized production of complexsystem for traditional Chinese medicine production process come true, andprovide an application demonstration for digital and intelligent manufacturingof Chinese medicine.

分享到: